Showing results (481-490 of 2,936) with videos related to
Sort By:
Pageof 294
Cancer Investigation|April 20, 2006
Continued use of trastuzumab (herceptin) after progression on prior trastuzumab therapy in HER-2-positive metastatic breast cancerLajos Pusztai, Francisco J EstevaCancer Investigation|May 28, 2010
In vivo and in vitro antitumor effects of a staphylococcal enterotoxin A mutant (SEA-H61D)Hai-Rong Wang, Hua Jiang, Huai-Jie Hao, et al.Cancer Investigation|September 30, 2010
Expression of HERV-K correlates with status of MEK-ERK and p16INK4A-CDK4 pathways in melanoma cellsZhongwu Li, Tao Sheng, Xiaohua Wan, et al.Cancer Investigation|July 3, 2010
Retinoblastoma protein-interacting zinc finger 1 (RIZ1) regulates the proliferation of monocytic leukemia cells via activation of p53Noman Mohammod Abu Shadat, Naoki Koide, Imtiaz I-E Khuda, et al.Cancer Investigation|July 2, 2010
The sequence-dependent cytotoxic effect of trastuzumab in combination with 5-Fluorouracil or cisplatin on gastric cancer cell linesXiao-Ling Li, Shao-Qiong Yi, Jian-Ming Xu, et al.Cancer Investigation|June 24, 2010
Overexpression of IGF-IR in malignant clonal cells in bone marrow of myelodysplastic syndromesQi He, Xiao Li, Zheng Zhang, et al.Cancer Investigation|August 10, 2010
Manganese superoxide dismutase expression as a function of genotype and lung cancer pathologyRobert C G Martin, Yan Li, Qiahong Liu, et al.Cancer Investigation|August 10, 2010
The endothelin axis stimulates the expression of pro-inflammatory cytokines and pro-migratory molecules in breast cancerAshley N Jewell, Muthulekha Swamydas, Claudia I Castillo, et al.Cancer Investigation|August 10, 2010
Population-based estimate of the prevalence of HER-2 positive breast cancer tumors for early stage patients in the USKathleen A Cronin, Linda C Harlan, Kevin W Dodd, et al.Pageof 294